| 000 | 01723 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518090046.0 | ||
| 264 | 0 | _c20210119 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a1950-6007 | ||
| 024 | 7 |
_a10.1016/j.biopha.2019.109702 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, Xiaoli | |
| 245 | 0 | 0 |
_a18α-Glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation. _h[electronic resource] |
| 260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cMay 2020 |
||
| 300 |
_a109702 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aDyslipidemias _xmetabolism |
| 650 | 0 | 4 |
_aFatty Acids _xmetabolism |
| 650 | 0 | 4 |
_aFructose _xpharmacology |
| 650 | 0 | 4 |
_aGlycyrrhetinic Acid _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGlycyrrhiza _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xmetabolism |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMitochondria _xpathology |
| 650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 700 | 1 | _aQiu, Linwei | |
| 700 | 1 | _aWang, Fen | |
| 773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 125 _gp. 109702 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2019.109702 _zAvailable from publisher's website |
| 999 |
_c30680901 _d30680901 |
||